Free Trial
OTCMKTS:GBIM

Globeimmune (GBIM) Stock Price, News & Analysis

Globeimmune logo

About Globeimmune Stock (OTCMKTS:GBIM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
410 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GBIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globeimmune and its competitors with MarketBeat's FREE daily newsletter.

GBIM Stock News Headlines

GlobeImmune, Inc. (GBIM) - Yahoo Finance
GlobeImmune, Inc. (GBIM)
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
BSPM Biostar Pharmaceuticals, Inc.
Bubang Co Ltd (014470)
Nihon Knowledge Co Ltd (5252)
See More Headlines

GBIM Stock Analysis - Frequently Asked Questions

Globeimmune, Inc. (OTCMKTS:GBIM) posted its quarterly earnings results on Thursday, May, 12th. The biopharmaceutical company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.12. The biopharmaceutical company had revenue of $0.94 million for the quarter.

Shares of GBIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Globeimmune investors own include Novavax (NVAX), OHR Pharmaceutical (OHRP), Premier Gold Mines (PG), Algonquin Power & Utilities (AQN), Nordic American Tankers (NAT), (BAA) (BAA) and Petroleo Brasileiro S.A.- Petrobras (PBR).

Company Calendar

Last Earnings
5/12/2016
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GBIM
Previous Symbol
NASDAQ:GBIM
CIK
1245104
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
-269.17
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:GBIM) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners